Matches in DBpedia 2016-04 for { ?s ?p "For the last three decades anticancer chemotherapy has concentrated on cisplatin derivates. In spite of their consistent side effects, cisplatin derivates have a central part in most anticancer treatments.In the search for drugs with fewer side effects other metal complexes have been examined over the past few years. Recent research shows that ruthenium complexes have interesting anticancer properties in vivo and they might be a good alternative to platinum-based drugs for anticancer therapy."@en }
Showing triples 1 to 4 of
4
with 100 triples per page.
- Ruthenium_anti-cancer_drugs abstract "For the last three decades anticancer chemotherapy has concentrated on cisplatin derivates. In spite of their consistent side effects, cisplatin derivates have a central part in most anticancer treatments.In the search for drugs with fewer side effects other metal complexes have been examined over the past few years. Recent research shows that ruthenium complexes have interesting anticancer properties in vivo and they might be a good alternative to platinum-based drugs for anticancer therapy.".
- Q17165015 abstract "For the last three decades anticancer chemotherapy has concentrated on cisplatin derivates. In spite of their consistent side effects, cisplatin derivates have a central part in most anticancer treatments.In the search for drugs with fewer side effects other metal complexes have been examined over the past few years. Recent research shows that ruthenium complexes have interesting anticancer properties in vivo and they might be a good alternative to platinum-based drugs for anticancer therapy.".
- Ruthenium_anti-cancer_drugs comment "For the last three decades anticancer chemotherapy has concentrated on cisplatin derivates. In spite of their consistent side effects, cisplatin derivates have a central part in most anticancer treatments.In the search for drugs with fewer side effects other metal complexes have been examined over the past few years. Recent research shows that ruthenium complexes have interesting anticancer properties in vivo and they might be a good alternative to platinum-based drugs for anticancer therapy.".
- Q17165015 comment "For the last three decades anticancer chemotherapy has concentrated on cisplatin derivates. In spite of their consistent side effects, cisplatin derivates have a central part in most anticancer treatments.In the search for drugs with fewer side effects other metal complexes have been examined over the past few years. Recent research shows that ruthenium complexes have interesting anticancer properties in vivo and they might be a good alternative to platinum-based drugs for anticancer therapy.".